| Catalog: | C0803A |
| Product Type: | Antibody |
| Reactivity: | H |
| Analysis mode: | IHC,ELISA |
| Host: | Rabbit |
| Clonality: | Polyclonal |
| Isotype: | IgG |
| Concentration: | 0.5 mg/mL |
| Storage: | -20℃ |
| Buffer: | PBS with 0.05% sodium azide and 50% glycerol, PH7.4 |
| Purification method: | Affinity purification |
| Application: | Cancer, Cell Biology, Immunology |
| Conjugation: | Unconjugated |
| Immunogen: | PD-1/CD279 |
| Swiss port: | Q15116 |
| Gene accession: | NP_005009 |
| Celluar localization: | Cytoplasm |
Programmed cell death 1 (PD-1, also known as CD279, Lupus La protein) is an immunosuppressive receptor that belongs to the CD28/CTLA-4 subfamily of the Ig superfamily. It is a type I transmembrane protein of 288 amino acids (aa). PD-1 is expressed during thymus development, and is induced in various surrounding hematopoietic cells through antigen receptor signaling and cytokines. The combination of PD-1 and its ligand PD-L1 or PD-L2 can transduce signals that inhibit T cell proliferation, cytokine production and cytolytic function. It is essential for the regulation of T cell function during immunity and tolerance. PD-1 blockade can overcome immune resistance and has been shown to have anti-tumor activity.
Copyright © 2025 Creative Biogene. All rights reserved.